Find an expert
Our panel of editors are available for interview
Professor Stephen Kaye
Editor-in-Chief BMJ Open Ophthalmology
Professor of Ophthalmology, Institute of Life Course and Medical Sciences, University of Liverpool where he leads the research into infections of the eye, Consultant Ophthalmologist Royal Liverpool University Hospital where he leads the Cornea and Ocular Surface Disease Service, Vice President of The Royal College of Ophthalmologists, Director of The Liverpool Research Eye Biobank, NHS England National lead for Corneal Transplantation, Honorary Professorship, Queens University, Belfast.
Professor Anna Maria Geretti
Editor-in-Chief of Sexually Transmitted Infections
Anna Maria Geretti, MD, PhD, FRCPath, is Professor of Virology & Infectious Diseases at the Institute of Infection & Global Health of the University of Liverpool, and Honorary Consultant at the Royal Liverpool University Hospital. She trained in Italy, the Netherlands and the UK and has a special interest in HIV, hepatitis B and hepatitis C infection. She has published over 100 peer-reviewed articles, editorials, reviews and book chapters, runs capacity building programmes for resource-limited countries and enthusiastically shares her expertise to train doctors and scientists.
Dr Ellen Weber
Editor-in-Chief of Emergency Medicine Journal
Dr Ellen Weber is an emergency medicine physician in San Francisco, California. She received her medical degree from Harvard Medical School and has been in practice for more than 20 years. She has worked clinically in community, county and academic emergency departments, and conducts research in topics related to health policy. She is currently a Professor of Emergency Medicine and Vice Chair at UCSF.
Professor Ganesan Karthikeyan
Editor-in-Chief Open Heart
Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.
